FCHO2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.354600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.558000E-01
Normal-vs-Stage2
7.241000E-01
Normal-vs-Stage3
6.298200E-02
Normal-vs-Stage4
9.705800E-01
Stage1-vs-Stage2
9.499600E-01
Stage1-vs-Stage3
3.513900E-02
Stage1-vs-Stage4
6.109400E-01
Stage2-vs-Stage3
5.690400E-02
Stage2-vs-Stage4
6.467600E-01
Stage3-vs-Stage4
5.865700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.916600E-01
Normal-vs-AfricanAmerican
9.891400E-01
Normal-vs-Asian
3.904800E-01
Caucasian-vs-AfricanAmerican
4.400000E-01
Caucasian-vs-Asian
4.021200E-01
AfricanAmerican-vs-Asian
2.931600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.618200E-01
Normal-vs-Female
6.174200E-01
Male-vs-Female
8.648200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.489400E-01
Normal-vs-Age(41-60Yrs)
9.119400E-01
Normal-vs-Age(61-80Yrs)
5.365600E-01
Normal-vs-Age(81-100Yrs)
4.323600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.493200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.975400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.316600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.880200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.462800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.473600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.555800E-01
Normal-vs-Daily Drinker
5.237600E-01
Normal-vs-Weekly Drinker
6.643600E-01
Normal-vs-Occasional Drinker
7.858000E-01
Normal-vs-Social Drinker
6.342800E-01
Non Drinker-vs-Daily Drinker
7.211000E-01
Non Drinker-vs-Weekly Drinker
8.703000E-01
Non Drinker-vs-Occasional Drinker
5.494800E-01
Non Drinker-vs-Social Drinker
8.738000E-01
Daily Drinker-vs-Weekly Drinker
9.461600E-01
Daily Drinker-vs-Occasional Drinker
4.181400E-01
Daily Drinker-vs-Social Drinker
6.716400E-01
Weekly Drinker-vs-Occasional Drinker
5.838600E-01
Weekly Drinker-vs-Social Drinker
7.977000E-01
Occasional Drinker-vs-Social Drinker
7.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.737980E-01
Normal-vs-Grade 2
1.180240E-02
Normal-vs-Grade 3
1.785590E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.287890E-02
Grade 1-vs-Grade 3
9.043900E-03
Grade 1-vs-Grade 4
1.737980E-01
Grade 2-vs-Grade 3
3.462400E-01
Grade 2-vs-Grade 4
1.180240E-02
Grade 3-vs-Grade 4
1.785590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.589600E-01
Normal-vs-NonDiabetic
5.625400E-01
Diabetic-vs-NonDiabetic
4.248200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.557600E-01
Normal-vs-NoPancreatitis
5.808200E-01
Pancreatitis-vs-NoPancreatitis
3.886200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.444400E-01
Normal-vs-N1
7.083200E-01
N0-vs-N1
3.832800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.092600E-01
Normal-vs-TP53-NonMutant
6.544800E-01
TP53-Mutant-vs-TP53-NonMutant
3.908200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
